Year: 2009
Type: dissertation
Abstract: This thesis examined the role of an oral fat tolerance test (OFTT) and coffee on glucose intolerance in healthy men. At time 0h, subjects consumed an oral lipid challenge or water (OGTT). After 5h, subjects consumed caffeinated coffee (CAF), decaffeinated coffee (DECAF) or water (OFTT+OGTT). At 6h, subjects underwent a 2-h oral glucose tolerance test (OGTT), except in one treatment (OFTT). Consumption of the OFTT increased glucose concentrations during a subsequent OGTT (p<0.05). At 7h, the CAF trial produced the highest glucose levels (p<0.05). Moreover, glucagon-like peptide-1 active (GLP-1a) and glucose-dependent insulinotropic polypeptide (GIP) were both increased for up to 6h in all OFTT trials (p<0.05). CAF and DECAF produced the highest GLP-1a response at 6.25h (p<0.05), while only CAF increased GIP secretion (p<0.05). These data suggest that lipids and caffeinated coffee can independently and additively decrease glucose tolerance. It also suggests that incretins could modulate in part glucose tolerance.
Author: Beaudoin, Marie-Soleil
Institution: University of Guelph
Language: English
Topic: Coffee research and impacts
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7052594293
